New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
10:11 EDTCDE, TROV, PDCO, SNSS, RLOC, TAP, FANG, PRAN, PBCT, BREW, BLK, ABT, LNCO, HTA, CPTS, SAM, INXN, DVA, CNSI, ARRY, LXP, IECOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abbott (ABT) initiated with an Outperform at William Blair... Array BioPharma (ARRY) initiated with an Outperform at Wells Fargo... BlackRock (BLK) initiated with an Overweight at JPMorgan... Boston Beer (SAM) initiated with a Neutral at Citigroup... Comverse (CNSI) initiated with a Neutral at JPMorgan... Conceptus (CPTS) initiated with a Buy at Stifel Nicolaus... Craft Brew (BREW) initiated with a Neutral at Citigroup... DaVita (DVA) initiated with an Overweight at JPMorgan... Healthcare Trust (HTA) initiated with an Outperform at Wells Fargo... IEC Electronics (IEC) initiated with a Buy at C.K. Cooper... InterXion (INXN) initiated with a Neutral at Goldman... Lexington Realty (LXP) initiated with a Buy at Jefferies... LinnCo (LNCO) initiated with an Outperform at Wells Fargo... Molson Coors (TAP) initiated with a Neutral at Citigroup... Patterson Companies (PDCO) initiated with a Buy at Stifel Nicolaus... People's United (PBCT) initiated with an Underweight at Evercore... ReachLocal (RLOC) initiated with a Buy at Janney Capital... Sunesis (SNSS) initiated with an Outperform at Wells Fargo... Trovagene (TROV) initiated with a Buy at Roth Capital... Prana (PRAN) initiated with an Outperform at Burrill... Coeur d’Alene Mines (CDE) initiated with an Accumulate at Global Hunter... Diamondback Energy (FANG) initiated with a Market Perform at Raymond James.
News For ABT;ARRY;SAM;BLK;CNSI;CPTS;BREW;DVA;HTA;IEC;INXN;LNCO;LXP;TAP;PDCO;PBCT;RLOC;TROV;PRAN;SNSS;CDE;FANG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 20, 2015
09:19 EDTINXNBofA/Merrill data center analyst holds an analyst/industry conference call
Subscribe for More Information
09:02 EDTABTAbbott receives FDA approval and launches iDesign Advanced WaveScan system
Subscribe for More Information
08:38 EDTABTAnalyst predicts Zoetis merges with Bayer unit, not Valeant
Zoetis (ZTS) in recent months has been the subject of takeover speculation, possibly for Valeant (VRX), but a Jefferies analyst told investors today in a research note that he views a deal with a unit of healthcare giant Bayer (BAYRY) as "highly likely" for the animal medicine company. BACKGROUND: Bill Ackman of Pershing Square, who owns stakes in both Zoetis and Valeant, said in early May while speaking on CNBC that Zoetis is a "great” business on a standalone basis, but he also spoke of the company's strategic value. Ackman added, however, that he was "not sure" that Valeant was the best acquirer of Zoetis. Subsequently, in late June, The Wall Street Journal reported that Valeant made a preliminary approach regarding a potential deal to buy Zoetis. CNBC's David Faber said the next day, citing his own sources, that Valeant reached out to Zoetis as a courtesy to common shareholder Ackman and was unlikely to pursue an acquisition of the company, though he cautioned then Valeant could change its approach and pursue a deal. BAYER: Jefferies analyst Jeffrey Holford said in a note today that he views a tie-up between Zoetis and Bayer's Animal Health business in 2016 as "highly likely." He sees Mylan's (MYL) acquisition of Abbott's (ABT) non‑U.S. developed markets specialty and branded generics business as a potential proxy for how a transaction could be structured, adding that such a "spinversion" could achieve up to 36% long-term earnings accretion for Zoetis. Holford reiterated a Buy rating on Zoetis with a $60 price target, while downgrading Bayer to Hold, citing valuation following the recent outperformance of its shares. IDEXX: While being discussed as a target, some analysts have also opined on companies that Zoetis could pursue as a buyer. On June 29, Canaccord said that in investor meetings with IDEXX (IDXX) executives declined to comment on Zoetis' potential interest in scaling up its animal health diagnostics business. Canaccord added that it thought Zoetis could make a bid for IDEXX. The firm reiterated its Buy rating and $80 price target on IDEXX shares at that time. PRICE ACTION: Since June 25, the day the Journal first reported on Valeant's preliminary takeover approach to Zoetis, the animal health company's shares have dropped nearly 4%. Zoetis closed down 20c to $47.80 on Friday.
07:33 EDTABTInternational AIDS Society to hold a conference
Subscribe for More Information
07:30 EDTABTZoetis 'highly likely' to merge with Bayer unit in 2016, says Jefferies
Subscribe for More Information
July 17, 2015
08:47 EDTTROVTrovagene 4M share Spot Secondary priced at $8.75
Subscribe for More Information
July 16, 2015
19:04 EDTTROVOn The Fly: After Hours Movers
Subscribe for More Information
16:34 EDTTROVTrovagene files to sell common stock, no amount given
Subscribe for More Information
16:15 EDTPBCTPeople's United reports Q2 operating EPS 21c, consensus 21c
Subscribe for More Information
15:02 EDTPBCTNotable companies reporting after market close
Subscribe for More Information
11:40 EDTTAPStocks with call strike movement; TAP HAL
Molson Coors (TAP) October 80 call option implied volatility decreased 5% to 32, Halliburton (HAL) October 46 call option implied volatility decreased 3% to 29 according to IVolatility.
July 15, 2015
17:50 EDTBLKBlackRock CEO Fink expects Fed to raise rates in September
Subscribe for More Information
17:32 EDTBLKIcahn says BlackRock 'doesn't understand the risks'
Subscribe for More Information
17:24 EDTBLKBlackRock CEO Fink says ETFs create price transparency, liquidity
Larry Fink is speaking on CNBC.
17:19 EDTBLKIcahn says BlackRock a 'very dangerous company'
Subscribe for More Information
11:08 EDTABTFormula makers slip after Mead Johnson cuts guidance
Subscribe for More Information
08:35 EDTBLKCNBC to hold a conference
Subscribe for More Information
05:49 EDTBLKBlackRock reports Q2 assets under management up 3% to $4.72T
Subscribe for More Information
05:47 EDTBLKBlackRock reports Q2 operating income up 10% to $1.24B
Reports Q2 AUM growth of 3%. Reports $7.3B of long-term net outflows for Q2.
05:46 EDTBLKBlackRock reports Q2 adjusted EPS $4.96, consensus $4.80
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use